Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis

We describe the case of a patient that developed both viral (CMV) and bacterial pneumonia one month after alemtuzumab infusion for multiple sclerosis. Physicians dealing with this drug should be aware of this serious but treatable complication.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research